BioEnterprise Adds Four to Board
Cleveland, OH, July 20, 2005 -- BioEnterprise, the regional bioscience business formation, recruitment, and acceleration initiative, announced the addition of four new members to its Board of Directors.
Joining the board effective with the July meeting are:
* Alfred E. "Buz" Brown, Ph.D., President of the Houston-based early stage venture capital firm BCM Technologies
* Jeffrey Crisan, Principal of Boston-based Bain Capital Ventures
* Frederick R. Nance, Managing Partner of the Cleveland office of Squire, Sanders
* Mary Jane Saunders, Ph.D., Dean of the Cleveland State University College of Sciences
Dr. Saunders joins the board as a representative of Cleveland State University and replaces Trevor O. Jones in that capacity. Brown, Crisan, and Nance join as at-large members.
"We're pleased to welcome these new board members," said BioEnterprise Board Chairman Thomas R. Zenty, President and Chief Executive Officer of BioEnterprise co-founder University Hospitals Health System. "Attracting this caliber of talent to BioEnterprise, validates this initiative’s success to date and creates the foundation for continued growth into the future. In adding national board members, we are also increasing awareness of the region's bioscience efforts and developing even greater potential for collaborations between our assets and companies and national markets for research, commercialization, and capital."
About BioEnterprise
BioEnterprise is a business formation, recruitment, and acceleration effort designed to support the growth of bioscience companies. Located in Cleveland, BioEnterprise provides management counsel and support services to bioscience companies. BioEnterprise's partners are Case Western Reserve University, the Cleveland Clinic Foundation, University Hospitals Health System, Inc, and Summa Health System. Additional technology partners include the NASA Glenn Research Center, Cleveland State University, and NorTech.
The BioEnterprise Initiative comprises the collaborative activities of BioEnterprise Corporation, Case Research Institute Office of Technology Transfer, Cleveland Clinic Innovations, and Summa Enterprise Group. The combined efforts of these groups has created, recruited, and accelerated more than 35 companies in two and a half years.
Contact Information:
BioEnterprise
Paul Nickels or Baiju Shah
BioEnterprise
216.658.3966
Cell: 216.402.0510
pnickels@bioenterprise.com
www.bioenterprise.com